Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Inventory (2021 - 2025)

Historic Inventory for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $947898.0.

  • InMed Pharmaceuticals' Inventory fell 1408.96% to $947898.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $947898.0, marking a year-over-year decrease of 1408.96%. This contributed to the annual value of $961173.0 for FY2025, which is 2275.54% down from last year.
  • As of Q4 2025, InMed Pharmaceuticals' Inventory stood at $947898.0, which was down 1408.96% from $890807.0 recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Inventory registered a high of $2.5 million during Q2 2022, and its lowest value of $744839.0 during Q4 2023.
  • Its 5-year average for Inventory is $1.3 million, with a median of $1.2 million in 2024.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Inventory soared by 6317.46% in 2022, and later tumbled by 5383.72% in 2023.
  • Over the past 5 years, InMed Pharmaceuticals' Inventory (Quarter) stood at $988822.0 in 2021, then surged by 63.17% to $1.6 million in 2022, then plummeted by 53.84% to $744839.0 in 2023, then surged by 48.13% to $1.1 million in 2024, then fell by 14.09% to $947898.0 in 2025.
  • Its Inventory was $947898.0 in Q4 2025, compared to $890807.0 in Q3 2025 and $961173.0 in Q2 2025.